Abiopharma

🔍 Fleming William Fred Jr (Executive)

Company: PROCORE TECHNOLOGIES, INC. (PCOR)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 19,474 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 95,887.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 17,311 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 113,198.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents shares of common stock issuable upon the settlement of restricted stock units (the "RSUs"). One-twelfth (1/12th) of the RSUs vest quarterly on each February 20, May 20, August 20 and November 20 (each, a "Company Vesting Date"), beginning with the first Company Vesting Date following the vesting commencement date of February 20, 2026, and subject to the Reporting Person's continued service through each Company Vesting Date.
• F2: Represents shares of common stock issuable upon the settlement of restricted stock units (the "RSUs"). Three-fourths (3/4th) of the shares underlying the RSUs will vest on the first anniversary of May 20, 2026 (the "Vesting Commencement Date"), and one-fourth (1/4th) of the shares underlying the RSUs will vest on the second anniversary of the Vesting Commencement Date.